Pur­due Phar­ma signs guilty plea, preps $8B+ set­tle­ment on Oxy con­tro­ver­sy — re­port; Flag­ship brings in a comms chief

Pur­due Phar­ma may soon be sign­ing off on a guilty plea and an $8 bil­lion-plus set­tle­ment to wrap up its con­tro­ver­sial role dis­trib­ut­ing Oxy­Con­tin.

The AP has the break­ing sto­ry this morn­ing.

Pur­due filed for bank­rupt­cy last year, along with In­sys and fol­lowed by Mallinck­rodt, as it nav­i­gat­ed its way through a bliz­zard of lit­i­ga­tion sur­round­ing Oxy, which trig­gered an epi­dem­ic of abuse around the coun­try.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER